ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CRL vs ABSI // FREE CASH FLOW YIELD

Charles River Laboratories International Inc. (NYSE) VS. Absci Corporation (NASDAQ) • 15-METRIC TALLY: CRL 5 — ABSI 0
▲ FREE CASH FLOW YIELD LEADER: CRL
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRL VS. ABSI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CRL ABSI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 0.40% -35.00% +35.40 CRL /roic <GO>
EV/EBITDA & P/E Valuation 95.0x — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE 3.10% -4.53% +7.63 CRL /fcf-yield <GO>
Operating Margin 0.60% — — TIE /operating-margins <GO>
Net Profit Margin -3.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) -0.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.65 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 2/9 +4.00 CRL /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 72.7 62.4 +10.30 CRL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.15 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 23.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $17.95B $2.08B $15.88B CRL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CRL REV ABSI REV CRL GROSS % ABSI GROSS % CRL FCF ABSI FCF
FY 2025 $4.02B $0 — — $557.0M -$94.0M
FY 2024 $4.05B $4.5M — — $552.3M -$72.8M
FY 2023 $4.13B $5.7M — — $498.1M -$64.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRL // BETA 1.15
ABSI // BETA —